Since WNT5A inhibits breast cancer cell migration and invasion in part by reducing the levels of CD44 [38,39], we have explored if WNT5A signaling regulates the expression of this protein also in prostate cancer tissue. This evidence concerns the gene CD44 and prostate cancer.